Research article · 6 Oct 2026
Conference abstractPublished 18 Jul 2016
The effects of matrix metalloproteinase 3 on neuronal loss in the ganglion cell layer of rats after retinal ischemia/reperfusion (I/R)
Central South University, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Emerging evidences have demonstrated that matrix metalloproteinase 3 (MMP3) is involved in neuronal degeneration in central nervous system (CNS) by activating glia cells, promoting neuronal apoptosis and injuring the brainâÂ?Â? blood barrier (BBB). However, little known is that whether MMP3 can contribute to neuronal degeneration induced by retinal I/R. In our present study, we detected whether MMP3 is localized in adult rat retinae and investigated its relationship with neuronal loss in ganglion cell layer (GCL) after retinal I/R. We first found that MMP3 was widely expressed in many cell types throughout the layers of rat retinae, which including retinal ganglion cells (RGCs), bipolar cells, horizontal cells, amacrine cells, MÃ?¼ller cells, astrocytes and microglia cells. In next experiments, all rats were treated with acute high intraocular pressure (aHIOP), to mimic the retinal I/R injury, for 1 hour (h) and sacrificed at different survival time points after aHIOP: 6 h, 1 day (d), 3 d and 7 d. We found that the aHIOP treatment increased the expression of both proenzyme MMP3 and active MMP3 compared to the normal control but it didn’t alter their laminar distribution pattern. Moreover, inhibiting the expression of MMP3 by the inhibitor NNGH ameliorated the loss of neuronal loss in GCL following aHIOP. Taken together, our data demonstrate that MMP3 is expressed in multiple types of retinal neurons and glia cells. Meanwhile, the up-regulated expression and activity of MMP3 is involved in the loss of neuronal loss in GCL after I/R. This study was supported by National Natural Science Foundation of China (No. 81371011,No.81400399), the Project of Innovation-driven Plan of Central South University (2015CXS022) , and National Key Technologies Research and Development Program of China (2012BAK14B03).
Subjects
Ophthalmology & OptometryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.
More from this journal
The newest in Journal of Clinical and Experimental Ophthalmology.
Short communication · 30 Aug 2026
Vision Science in the Modern Era: Integrating Neuroscience, Genetics, and Technology
Commentary · 3 Aug 2026
Emerging Frontiers in Experimental Ophthalmology: Innovations and Translational Challenges
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Experimental Ophthalmology
- SubjectOphthalmology & Optometry
- BylineArticles whose byline prints “Shuchao-Wang”
- BylineArticles whose byline prints “Tu Hu”
- BylineArticles whose byline prints “Jufang Huang”
- BylineArticles whose byline prints “Dan Chen”
